361 related articles for article (PubMed ID: 17164822)
1. There and back again: a tale of norepinephrine and drug addiction.
Weinshenker D; Schroeder JP
Neuropsychopharmacology; 2007 Jul; 32(7):1433-51. PubMed ID: 17164822
[TBL] [Abstract][Full Text] [Related]
2. Prefrontal cortical norepinephrine release is critical for morphine-induced reward, reinstatement and dopamine release in the nucleus accumbens.
Ventura R; Alcaro A; Puglisi-Allegra S
Cereb Cortex; 2005 Dec; 15(12):1877-86. PubMed ID: 15728739
[TBL] [Abstract][Full Text] [Related]
3. Norepinephrine and stimulant addiction.
Sofuoglu M; Sewell RA
Addict Biol; 2009 Apr; 14(2):119-29. PubMed ID: 18811678
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the brain histaminergic system in addiction and addiction-related behaviors: a comprehensive review with emphasis on the potential therapeutic use of histaminergic compounds in drug dependence.
Brabant C; Alleva L; Quertemont E; Tirelli E
Prog Neurobiol; 2010 Nov; 92(3):421-41. PubMed ID: 20638439
[TBL] [Abstract][Full Text] [Related]
5. Brain mechanisms of drug reward and euphoria.
Wise RA; Bozarth MA
Psychiatr Med; 1985; 3(4):445-60. PubMed ID: 2893431
[TBL] [Abstract][Full Text] [Related]
6. Bromocriptine treatment for cocaine abuse: the dopamine depletion hypothesis.
Dackis CA; Gold MS; Davies RK; Sweeney DR
Int J Psychiatry Med; 1985-1986; 15(2):125-35. PubMed ID: 3902694
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence.
Le Foll B; Goldberg SR
J Pharmacol Exp Ther; 2005 Mar; 312(3):875-83. PubMed ID: 15525797
[TBL] [Abstract][Full Text] [Related]
8. The effects of acetaldehyde on nicotine-induced transmitter levels in young and adult brain areas.
Sershen H; Shearman E; Fallon S; Chakraborty G; Smiley J; Lajtha A
Brain Res Bull; 2009 Aug; 79(6):458-62. PubMed ID: 19389462
[TBL] [Abstract][Full Text] [Related]
9. The neurobiology of addiction: a neuroadaptational view relevant for diagnosis.
Koob GF
Addiction; 2006 Sep; 101 Suppl 1():23-30. PubMed ID: 16930158
[TBL] [Abstract][Full Text] [Related]
10. Dopamine beta-hydroxylase knockout mice have alterations in dopamine signaling and are hypersensitive to cocaine.
Schank JR; Ventura R; Puglisi-Allegra S; Alcaro A; Cole CD; Liles LC; Seeman P; Weinshenker D
Neuropsychopharmacology; 2006 Oct; 31(10):2221-30. PubMed ID: 16395294
[TBL] [Abstract][Full Text] [Related]
11. Drug addiction. Part II. Neurobiology of addiction.
Vetulani J
Pol J Pharmacol; 2001; 53(4):303-17. PubMed ID: 11990077
[TBL] [Abstract][Full Text] [Related]
12. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.
Rothman RB; Baumann MH; Dersch CM; Romero DV; Rice KC; Carroll FI; Partilla JS
Synapse; 2001 Jan; 39(1):32-41. PubMed ID: 11071707
[TBL] [Abstract][Full Text] [Related]
13. Selective antagonism at dopamine D3 receptors as a target for drug addiction pharmacotherapy: a review of preclinical evidence.
Heidbreder C
CNS Neurol Disord Drug Targets; 2008 Nov; 7(5):410-21. PubMed ID: 19128200
[TBL] [Abstract][Full Text] [Related]
14. Reward deficiency syndrome: genetic aspects of behavioral disorders.
Comings DE; Blum K
Prog Brain Res; 2000; 126():325-41. PubMed ID: 11105655
[TBL] [Abstract][Full Text] [Related]
15. The effects of chronic administration and withdrawal of (+)-amphetamine on seizure threshold and endogenous catecholamine concentrations and their rates of biosynthesis in mice.
Riffee WH; Gerald MC
Psychopharmacology (Berl); 1977 Jan; 51(2):175-9. PubMed ID: 402670
[TBL] [Abstract][Full Text] [Related]
16. Noradrenergic and dopaminergic effects of (+)-amphetamine-like stimulants in the baboon Papio anubis.
Alexander M; Rothman RB; Baumann MH; Endres CJ; Brasić JR; Wong DF
Synapse; 2005 May; 56(2):94-9. PubMed ID: 15729739
[TBL] [Abstract][Full Text] [Related]
17. Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis.
Blum K; Gold MS
Med Hypotheses; 2011 Apr; 76(4):576-84. PubMed ID: 21306831
[TBL] [Abstract][Full Text] [Related]
18. Chronic neuropharmacology of cocaine: progress in pharmacotherapy.
Gawin FH
J Clin Psychiatry; 1988 Feb; 49 Suppl():11-6. PubMed ID: 3276669
[TBL] [Abstract][Full Text] [Related]
19. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs.
Cunha-Oliveira T; Rego AC; Oliveira CR
Brain Res Rev; 2008 Jun; 58(1):192-208. PubMed ID: 18440072
[TBL] [Abstract][Full Text] [Related]
20. Opioid and nondopamine reward circuitry and state-dependent mechanisms.
Fujita M; Ide S; Ikeda K
Ann N Y Acad Sci; 2019 Sep; 1451(1):29-41. PubMed ID: 29512887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
